Cellular and Molecular Gastroenterology and Hepatology · 2019 · 50 citations · 24 references
MedicineImmunologyPathologyHepatologyInflammationInnate ImmunityBiliary Tract DiseaseBiomarkers Of Liver InjuryCholestatic Liver InjuryHepatobiliary DiseaseInflammasome ActivationLiver DiseaseAnimal Models Of CholestasisCholangiocyte Injury BiomarkersCholestasis BiomarkersCholestasis PathophysiologyHepatic Inflammatory InjuryInflammatory Liver InjuryLiver Injury MechanismsNlrp1 Inflammasome
BACKGROUND & AIMS: Inflammation plays an important role in the pathogenesis of cholestatic liver injury, but it is unclear whether the inflammasome is involved and is the objective of this study. METHODS: ) mice for 7 days. Mouse hepatocytes and macrophages were treated with bile acids. RESULTS: BDL livers had more M2 anti-inflammatory macrophages evidenced by more CD206 positive cells and higher expression of IL-4, CD163, Fizz1 and IL-33. When mouse hepatocytes and peritoneal macrophages were exposed to cholestatic levels of major endogenous bile acids (300μM TCA), neither IL-1β induction nor procaspase-1 cleavage were detected. CONCLUSIONS: The inflammasome exacerbates cholestatic liver injury, but bile acids do not directly activate the inflammasome.
24
Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme
Keisuke Kuida, Judith A. Lippke, George Ku et al. · Science · 1995 · 1.6K citations
Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome
Chuansheng Guo, Shujun Xie, Zhexu Chi et al. · Immunity · 2016 · 823 citations · Full text
Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis
Haiping Hao, Lijuan Cao, Changtao Jiang et al. · Cell Metabolism · 2017 · 463 citations · Full text